Home | Sitemap | Imprint
 
Search:
 
 
   
DGRA INTRANET
 
   
Internal information for members.
Name:
Password:
Forgotten your password?
   
BUSINESS OFFICE:
 
   
Adenauerallee 15
D-53111 Bonn,
Germany

Phone: +49 (0)228 368264-6
Fax: +49 (0)228 368264-7
E-Mail: info@dgra.de
 
DRUG REGULATORY AFFAIRS COURSE
Module 2: Pharmaceutical Law

Method of examination: Course work and written or oral examination
Credit points: 6

Module Head: Prof. Burkhard Sträter

 

Topics

   
 

The German Drug Law in the legal context of civil, penal and public-law standards

  • Approval procedures for marketing authorization, renewal of marketing authorization and manufacture of pharmaceuticals
  • Procedures for extending marketing authorizations
  • Revocation and limitations of marketing authorizations in the so-called Step Plan Procedure
  • Tasks and responsibilities of the Production, Control Sales, Information, Stage Plan officers as defined by the German Drug Law
  • Control of pharmaceutical imports and exports

Law on Administrative Procedure (VwVfG): Relevance to administrative procedures according to the German Drug Law (AMG)

  • Basic principles of an administrative procedure
  • Rights of those involved (e.g. right to: a hearing, examination of files, protection of company and business secrets)
  • Legal remedy (objection procedure)
  • Types, relevance and calculation of procedural deadlines in respect of the AMG
  • Failure to meet deadlines (consequences, requirements for reinstatement)

Marketing authorization of generics – intellectual property rights of the original manufacturer

  • Requirements for the dossier
  • Utilization of documents of the first registrant
  • Limits to the intellectual property rights of the originator– Significance of patents, so-called protection certificates and document protection

The EU legal system relating to the production, marketing authorization and marketing of pharmaceuticals

  • Judicial quality of EU standards
  • EU system for the marketing authorization of pharmaceuticals
  • Comparison of the centralized and decentralized marketing authorization procedures

Conditions for the importation, parallel imporation and mail order supply of pharmaceuticals

  • Significance of the free movement of goods and the country-of-origin principle
  • Requirements for and differences between importation from EU member states and importation from non-EU countries
  • Mutual Recognition Agreements (MRAs)
  • Practice of the European Count in respect of parallel imports
  • Liberalization of mail-order trade by the Healthcare System Modernization Law (GMG)

Clinical drug testing

  • Requrements and control system according to the German Drug Law and the EU guidance note draft
  • Supervisory functions of the authorities concerned
  • Notification and approval procedures
  • Significance of ethics committees and the professional code of conduct for doctors
  • Judicial quality and significance of the the GCP guidelines

Characteristics of pharmaceuticals in contradistinction to foods and cosmetics

  • Definition and essential distinuishing criteria according to EU law, the German Drug Law and the Food and Feed Code (LFGB)
  • Significance formoterol the marketability of so-called borderline products

Pharmaceutical advertising law

  • Provisions of EU law and their implementation in the German Pharmaceutical Advertising Law (HWG) and the German Drug Law (AMG)
  • Structure and content of the HWG
  • Supervisory powers of the authorities
  • Significance of the the Advertising Law for the control of pharmaceutical advertising according to the German Law against Unfair Competition (UWG)
  • Limits of advertising and marketing on the internet

Significance of special laws on the production and use of pharmaceuticals – overview

  • The DNA Technology Law, Transfusion Law

Significance of special laws on the production and use of pharmaceuticals – overview

  • The Narcotics Law

 
« back
 
page up print
 
Studiengang (M.D.R.A.)
Abschluß: Master of Drug
Regulatory Affairs
mehr Informationen »
DGRA-Fortbildungen:
DGRA Workshops:

28. - 29. August 2012
Update Workshop

27. November 2012
Therapeutische Vaccine

Jahreskongresse:

30. - 31. Mai 2012
DGRA-Jahreskongress 2012

mehr Fortbildungen »
Job-Börse:
Angebot vom 10.04.2012
Leiter/-in Logistik

Angebot vom 30.03.2012
Manager Drug Regulatory Affairs (w/m)

mehr Stellenangebote »
© 2011, DGRA e.V.
Letzte Aktualisierung am:
Samstag, 02.10.2010